Is a(n inborn) deficiency of prostacyclin synthesis stimulating plasma factor associated with increased lipoprotein(a)?

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 5, 1996, Pages 363-372

  Kritz, H ^a,b   Pidlich, J ^c   O'Grady, J ^d   Sinzinger, H ^a,c  

^a Wilhelm Auerswald Atherosclerosis Research Group   (Austria)

^b Rehab Center Engelsbad Melanie   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; LIPOPROTEIN A; PROSTACYCLIN;

ADULT; AGED; ANIMAL TISSUE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEFICIENCY; FAMILY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID ANALYSIS; MALE; META ANALYSIS; NONHUMAN; NORMAL HUMAN; PLASMA FACTOR; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; THROMBOCYTE AGGREGATION; VASCULAR DISEASE; VASCULAR TISSUE;

ANIMALIA;

EID: 0029987349     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90043-5     Document Type: Article

References (42)

1. Leithner C., Sinzinger H., Angelberger P., Syré G. Indium-111 labelled platelets in chronic kidney transplant rejection. Lancet 1980; i: 213-214.
2. Defreyn G., Dauden M. V., Machin S. J., Vermylen J. A plasma factor in uremia which stimulates prostacyclin release from cultured endothelial cells. Thromb Res 1980; 19: 695-699.
3. Remuzzi G., Mecca G., Livio M. et al. Prostacyclin generation by cultured endothelial cells in haemolytic uraemic syndrome. Lancet 1980; i: 656-687.
4. Remuzzi G., Perico N. Prostacyclin in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. In: Wu K. K., Rossi E. C., eds. Prostaglandins in clinical medicine. New York: Raven Press, Yearbook Medical Publ 1980:319.
5. Feinstein D. I. Lupus anticoagulant, thrombosis and fetal loss. N Engl J Med 1985; 313: 1348-1350.
6. Remuzzi G., Zoja C., Marchesi D. et al. Plasmatic regulation of vascular prostacyclin in pregnancy. Br Med J 1981; 282: 512-514.
7. Hoche Ch., Kefalides A., Dadak C., Sinzinger H. Platelet sensitivity to prostacyclin and prostaglandin in pregnancy and puerperium. In: Lewis P. J., ed. Prostacyclin in pregnancy. New York: Raven Press, 1983: 112.
8. Harris N. N., Gharavi A. E., Boey M. L. et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211-1213.
9. Ono Y., Hashimoto T., Umeda F, et al. Expression of prostacyclin-stimulating factor, a novel protein, in tissues of Wistar rats and in cultured cells. Biochem Biophys Res Commun 1994; 202: 1490-1496.
10. Berg K. A new serum type system in man. The Lp system. Acta Pathol Microbiol Scand Suppl 1963; 59: 166-167.
11. Schreiner P. J., Chambless L E., Brown S. A., Watson R. L., Toole J., Heiss G. Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol 1994; 4: 351-359.
12. Dahlen G. H., Gyuton J. R., Attar M., Farmer J. A., Kautz J. A., Gotto A. M. Association of levels of lipoprotein Lp(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 2540-2544.
13. Scanu A. M. Lipoprotein(a): a potential bridge between the fields of atherosclerosis and thrombosis. Arch Pathol Lab Med 1988; 112: 1045-1047.
14. Constans J., Pellegrin J. L., Peuchant E. et al. High plasma lipoprotein(a) in HIV-positive patients. Lancet 1993; i: 1099-1100.
15. Yamazaki M., Asakura H., Jokaji H. et al. Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome. Thromb Haemost 1994; 71: 427-429.
16. Sinzinger H., Husslein P., Peskar B. A. Defects in the prostaglandin system. IV. Inborn, non-familial plasma factor deficiency. Wien Klin Wochenschr 1985; 97: 722-726.
17. Sinzinger H., Fitscha P. Defects in the prostaglandin system. I. Familial total plasma factor deficiency. Wien Klin Wochenschr 1985; 97: 73-76.
18. Csonka E. Techniques for culturing arterial endothelial cells. Adv Exp Med Biol 1977; 82: 719-723.
19. 2)-Synthese. In: Deutsch E., Lechner K., eds. Fibrinolyse, Thrombose, Hämostase. Stuttgart: Schattauer, 1980:607.
20. Silberbauer K., Sinzinger H., Winter M. Prostacyclin production by vascular smooth muscle cells. Lancet 1978; i: 1356.
21. Sinzinger H., Flores J., Rauscha F. Prevalence of plasma factor deficiency in the Viennese population. Results of a screening study of 1300 adults. Klin Wochenschr 1988; 66: 779-783.
22. Moncada S., Gryglewski R. J., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin peroxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663-665.
23. Radomski M. W., Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 1993; 70: 36-41.
24. 1 and nitric oxide (NO). Thromb Res 1991; 62: 299-304.
25. 123iodine-low-density lipoprotein scintiscanning. Ann NY Acad Sci 1995; 748: 613-621.
26. 1 on in vitro oxidation of human low-density lipoproteins. Adv Prostaglandin Thromboxane Leukot Res 1995, 23: 409-411.
27. 1 treatment in rabbits. J Cardiovasc Pharmacol 1993; 21: 503-506.
28. McIntyre G. E., Pearson J. D., Gordon J. L. Localisation and stimulation of prostacyclin production in vascular cells. Nature 1978; 271: 549.
29. Polterauer P., Peskar B. A., Sinzinger H. Plasma factor activity in terminal hepatic failure. Prostaglandins Leukot Med 1984; 13: 315-322.
30. Sinzinger H., Kaliman J., Peskar B. A. Prostacyclin-synthesis stimulating plasma factor in coronary heart disease. Prostaglandins Leukot Med 1986; 24: 15-25.
31. Sinzinger H., Kaliman J., Strobl-Jäger E., Widhalm K., Peskar B. A. Prostacyclin-synthesis stimulating plasma factor in patients with primary hyperlipoproteinemia-effect of dietary and drug treatment. Prostaglandins Leukot Med 1986; 22: 179-189.
32. Dadak C., Kefalides A., Sinzinger H. Prostacyclin-synthesis stimulating plasma factor and platelet sensitivity in preeclampsia. Biol Res Pregnancy Perinatol 1985; 6: 65-69.
33. Yamauchi T., Umeda F., Masakado M., Ono Y., Nawata H. Serum-free conditioned medium of human diploid fibroblast cells contain an activity that stimulates prostacyclin production by cultured bovine aortic endothelial cells. Biochem Mol Biol Int 1993; 31: 65-71.
34. 2-stimulating factor. Biochem J 1996; in press.
35. Inoguchi T., Umeda F., Watanabe J., Ibayashi H. Stimulatory activity on prostacyclin production decreases in sera from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 1987; 3: 243-248.
36. Inoguchi T., Umeda F., Ono H., Hunisaki M., Watanabe J., Nawata H. Abnormality in prostacyclin-stimulatory activity in sera from diabetics. Metabolism 1989; 38: 837-842.
37. Strobl-Jäger E., Kaliman J., Sinzinger H. Prostacyclin synthesis stimulating plasma factor in patients with peripheral vascular disease. Prostaglandins Leukot Med 1987; 28: 313-323.
38. Eaton D. L, Fless G. M., Kohr W.J. et al. Partial amino acid sequence of lipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 1987; 84: 3224-3228.
39. Edelberg J. M., Pizzo S. V. Lipoprotein(a) inhibits plasminogen activation in a template-dependent manner. Blood Coagulat Fibrinol 1991; 2: 759-764.
40. Habib A., Martinuzzo M. E., Carreras L. O., Levy-Toledano S., Maclouf J. Increased expression of inducible cyclooxygenase-2 in human endothelial cells by antiphospholipid antibodies. Thromb Haemost 1995; 74: 770-777.
41. Utermann G. The mysteries of Lipoprotein(a). Science 1989; 246: 904-910.
42. Morishita E., Matsuda T. Lipoprotein(a) on atherosclerosis and thrombosis. Geriatr Med 1992; 30: 1795-1800.